A Double-blind, Randomized, 2-Period Crossover Study to Compare the Safety and Tolerability of a Titration of Sustained Release Formulation Quetiapine Fumarate (SEROQUEL) with Placebo in Healthy Volunteers
Study identifier:D1448C00013
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Double-blind, Randomized, 2-Period Crossover Study to Compare the Safety and Tolerability of a Titration of Sustained Release Formulation Quetiapine Fumarate (SEROQUEL) with Placebo in Healthy Volunteers
Medical condition
schizophrenia
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Sept 2005
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
